Lohia Sees No Order-Book Peaking, Targets 85% Utilization

Lohia Corp Limited — Q1 FY27 Earnings Call (held Aug 20, 2026; results for quarter ended Jun 30, 2026)

1. Overall Tone of Management: Optimistic

• Management highlighted strong momentum and “healthy visibility” from the order book, with clear confidence that the cycle is not yet at a peak (“we do not see a peaking of this order in the near future”).
• They repeatedly framed performance as sustainable/“new normal” (e.g., EBITDA margin range) and provided constructive forward-looking targets (revenue growth range, capacity utilization, execution timelines).

2. Key Themes from Management Commentary

• Strong demand / order book build-up
• Revenue growth of ~60% YoY and order book reaching ~INR1,778–1,780 cr with visibility into coming quarters.
• Drivers cited: end-product application expansion (including non-packaging), and reduced relevance of “single-use plastics” bans to their end markets.
• Innovation-led differentiation
• New product launches (e.g., CoEx 1600, nova 6 plus, FIBC cutting/bag machines) and continued in-house R&D.
• Operational excellence & cost discipline
• Focus on “doing more with the resources we already have”: productivity, waste reduction, lead time shortening, supply chain responsiveness, and digital tools.
• Customer lifecycle support
• Remote assistance center, rebuilding/service approach, and operator training via TTRC (3-month residential certification program).
• Working capital/cash generation focus
• Net working capital cycle improved slightly (~81 days vs ~84 days), with emphasis on managing inventory/receivables/advances.
• Measured investment + balance sheet discipline
• “Selective” investments in product development, automation, digitalization, and recycling/monofilament solutions; “measured” approach to maintain net debt-negative stance.
• Capacity expansion plan framed as light-capex
• Capacity utilization target up to ~85%, with incremental capex described as manageable and not requiring major new plans immediately.

3. Q&A Analysis

Theme A: Why order book surged / sustainability of demand

• Core questions
• What caused the steep order book jump (from ~INR1,358 cr in FY26 to ~INR1,800 cr by Jun’26)?
• Is this a peak upcycle or planned/segment-driven?
• Management response
• Post-COVID investment slump is “seeing an uptick” for 2–3 years.
• Customers expanding meaningfully; growth in non-packaging applications and applicability beyond single-use plastics.
• “We do not see a peaking of this order in the near future” and “Peak is still to go achieve.”
• Assessment
• Strong confidence, but largely macro/industry narrative rather than quantified evidence (no explicit order conversion or segment-level breakdown).

Theme B: Domestic vs export mix and outlook

• Core questions
• With exports down in share, is domestic capex driving the order book?
• Will exports “make a comeback” to ~50% revenue/order book?
• Management response
• Current order book driven by domestic investments.
• Exports expected to stabilize around ~50% of revenue (citing historical export range 45%–55%).
• Assessment
• Clear qualitative direction; no explicit timeline for export recovery.

Theme C: Margin sustainability and drivers

• Core questions
• Is the jump to ~20% EBITDA margin one-time or sustainable?
• How did margins remain resilient despite commodity inflation?
• Will domestic-heavy mix pressure margins?
• Management response
• “Pre-COVID” EBITDA margins were 15%–20%; they believe regaining this range is the “new normal.”
• Margin resilience attributed to:
  1) Revisiting sales prices to match recent input material prices
  2) Short/medium-term supplier contracts
  3) Tweaking discount structure
• Domestic mix: management said margins “will not take a hit” due to planning/coverage.
• Assessment
• Mostly direct and specific on mechanisms (pricing, contracts, discounting).
• However, they also avoided hard forward EBITDA guidance (“We do not give any guidance on the EBITDA number going forward”).

Theme D: Execution timing, revenue modeling, and capacity utilization

• Core questions
• Inquiry pipeline conversion rate and how much converts into orders in the year.
• Execution cycle (6–9 months assumed) and whether most orders execute in FY27.
• Capacity utilization targets and peak utilization.
• Management response
• Inquiry conversion: ~10%–15% of inquiries convert to executable orders (backed by advances), typically over 2–3 years.
• Execution period for new orders: 6–9 months on average.
• Capacity utilization: currently ~75% (later clarified ~70–72%), with leeway to ~85%.
• Revenue modeling implication: one analyst inferred INR2,150–2,200 cr for the year; management replied “Should be like that.”
• Assessment
• Some numerical inconsistency: utilization stated as ~75% then clarified to ~70–72%.
• “Should be like that” is supportive but not formal guidance.

Theme E: Pricing power vs China / competitive dynamics

• Core questions
• Does rupee depreciation help win export share vs Starlinger/China?
• Are customers paying a premium for technology/quality?
• Management response
• Southeast Asia competition: mainly Chinese; rupee depreciation helps negotiations and discounts, but must maintain profitability.
• They claim a premium over China: “We get premium over China” and later quantified: “15% to 20% higher prices than Chinese.”
• China’s weakness: “service is very weak” and operational/knowledge barriers.
• Assessment
• Strong competitive narrative; still acknowledges need to manage profitability and raw material/parts volatility.

Theme F: R&D spend, capex, and regulatory protection

• Core questions
• R&D plan and whether “hero product” launches are expected.
• Capex plan to support utilization ramp.
• Any regulatory tailwinds (BIS/customs) vs China.
• Management response
• R&D maintained at ~3% going forward; “hero products” are in confidential automation/IoT development.
• Capex: described as light; beyond current capacity, major capex not immediately planned; incremental expansion can be done in ~5–6 months (shed + equipment; land available).
• Regulatory: no BIS-type advantage; only that Chinese/European equipment faces custom duty, increasing their landed cost.
• Assessment
• Clear on capex timing and “light capex” framing; regulatory advantage is limited and mostly cost-based.

4. Guidance / Outlook

Explicit guidance (quantitative)

• Revenue growth expectation: 20%–25% (FY27/FY28 context asked; management: “We expect to grow in the range of 20% to 25%”).
• Capacity utilization / peak: current ~70–72% (also stated ~75% earlier) with potential to ~85%.
• Execution cycle: 6–9 months average for new orders.
• Service/spares revenue contribution: ~10%–12% of revenue from spare parts; 2%–3% of plant value annually as consumables/spares (as described in Q&A).
• R&D spend: ~3% of revenue going forward.
• Capex timing for expansion: ~5–6 months to go live for incremental capacity.
• EBITDA margin stance (qualitative, not formal guidance):
• They indicated EBITDA margin range 15%–20% historically and believe ~20% is sustainable as “new normal,” but also said they do not give EBITDA guidance.

Implicit signals (qualitative)

• Order book not peaking soon: “we do not see a peaking…” and “Peak is still to go achieve.”
• Exports to stabilize: expectation exports stabilize around ~50% of revenue/order book.
• Margins supported by pricing discipline: repeated emphasis on price resets, supplier contracts, and discount structure.
• Domestic-heavy mix should not hurt margins: “margins will not take a hit… sufficiently covered with our plannings.”
• Risk awareness: management highlighted macro/geopolitical uncertainty affecting raw materials/parts and therefore margins.

5. Standout Statements (direct / high-signal)

• Order cycle confidence
• “We do not see a peaking of this order in the near future.”
• “Peak is still to go achieve.”
• EBITDA “new normal”
• “Pre-COVID, we have always had this between 15% to 20%… We believe that this is going to be the new normal for us.”
• No EBITDA guidance
• “We do not give any guidance on the EBITDA number going forward.”
• Export stabilization
• “Exports would stabilize at around 50% of our revenue and order book going forward.”
• Pricing power vs China
• “We get premium over China” and later: “15% to 20% higher prices than Chinese currently.”
• Execution and revenue modeling support
• Analyst assumption of INR2,150–2,200 cr revenue for the year: “Should be like that.”
• Capex posture
• “We are a very light capex…” and major capex “yet to… started any plans around that.”
• Regulatory tailwind limitation
• “No, not really… other than… custom duty… I don’t see any other BIS or any other thing which favors us.”

6. Red Flags / Positive Signals

Red flags
– Utilization inconsistency: stated ~75% then clarified to ~70–72%—small, but signals potential imprecision in operational metrics.
– Limited hard forward guidance: strong qualitative confidence but no EBITDA guidance and no explicit segment-level demand quantification.
– Margin risk acknowledged but not quantified: geopolitical/raw material/parts volatility could affect margins (“who knows that, how the things will move tomorrow”).
– “Should be like that” revenue support is not formal guidance—could be optimistic given execution risk.

Positive signals
– Mechanistic explanation for margin resilience (pricing resets + supplier contracts + discount structure).
– Clear order book visibility with advances from customers (~20%).
– Light capex + fast expansion (5–6 months) supports ability to meet demand without heavy balance sheet strain.
– Customer lifecycle moat (remote assistance + training + service), used to defend against low-cost competition.

7. Historical Comparison & Consistency Analysis

Note: No prior earnings call transcripts were provided (“No documents matched the configured filters”), so historical comparison cannot be performed. All consistency/credibility analysis below is therefore limited to within this call only.

a. Change in Tone Over Time

• Not assessable (no prior transcripts provided).

b. Tracking Past Commitments vs Outcomes

• Not assessable (no prior transcripts provided).

c. Narrative Shifts

• Not assessable across periods (no prior transcripts provided).

d. Consistency & Credibility Signals (within this call)

• Credibility: Medium
• Strengths: specific operational mechanisms (pricing, supplier contracts), concrete numbers (order book, margins, conversion rate, execution cycle).
• Weaknesses: some metric inconsistency (utilization), and reliance on qualitative “no peak” assertions without quantified evidence.

e. Evolution of Key Themes

• Not assessable across calls (no prior transcripts provided).

f. Additional Insights (cross-period intelligence)

• Not assessable (no prior transcripts provided).